Brandes Investment Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-65,436
Closed -$4.75M 162
2021
Q4
$4.75M Buy
65,436
+703
+1% +$48.4K 0.1% 110
2021
Q3
$4.52M Buy
64,733
+7,176
+12% +$504K 0.1% 106
2021
Q2
$3.96M Buy
57,557
+26,633
+86% +$1.78M 0.09% 105
2021
Q1
$2.03M Buy
30,924
+7,765
+34% +$501K 0.05% 115
2020
Q4
$1.31M Buy
23,159
+1,360
+6% +$82.1K 0.03% 121
2020
Q3
$1.38M Sell
21,799
-7,930
-27% -$550K 0.05% 116
2020
Q2
$2.29M Sell
29,729
-39,478
-57% -$3.03M 0.07% 114
2020
Q1
$5.17M Sell
69,207
-10,188
-13% -$704K 0.18% 87
2019
Q4
$5.16M Sell
79,395
-460
-0.6% -$30K 0.12% 90
2019
Q3
$5.06M Sell
79,855
-3,345
-4% -$219K 0.13% 85
2019
Q2
$5.62M Sell
83,200
-9,522
-10% -$626K 0.13% 86
2019
Q1
$6.03M Buy
92,722
+8,966
+11% +$596K 0.14% 83
2018
Q4
$5.24M Buy
83,756
+12,985
+18% +$908K 0.13% 88
2018
Q3
$5.46M Buy
70,771
+8,874
+14% +$670K 0.12% 89
2018
Q2
$4.38M Buy
61,897
+824
+1% +$58.2K 0.1% 92
2018
Q1
$4.6M Sell
61,073
-4,723
-7% -$375K 0.1% 90
2017
Q4
$4.71M Sell
65,796
-4,466
-6% -$339K 0.1% 92
2017
Q3
$5.69M Sell
70,262
-40,458
-37% -$3.09M 0.12% 89
2017
Q2
$7.84M Buy
110,720
+1,964
+2% +$131K 0.12% 91
2017
Q1
$7.39M Buy
+108,756
New +$7.65M 0.11% 90

Other funds holding GILD

Brandes Investment Partners's GILD Position: Q1 2022 in Review

Brandes Investment Partners sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 65,436 shares — an estimated $4.75M sold.

Brandes Investment Partners first reported a position in GILD in Q1 2017 and held it in 20 quarters. The position peaked at $7.84M in Q2 2017. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Brandes Investment Partners reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Brandes Investment Partners sold 65,436 Gilead Sciences shares in Q1 2022, an estimated $4.75M.
  • Brandes Investment Partners first reported a position in Gilead Sciences in Q1 2017 and held it in 20 quarters.
  • Brandes Investment Partners's Gilead Sciences position peaked at $7.84M in Q2 2017.
  • 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Brandes Investment Partners's 13F filing for Q1 2022, filed 10 May 2022.